[Treatment of the secondary collateral toxic effects of antiblastic drugs].
D000311:Adrenal Glands; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001247:Asthenia / Q000188:drug therapy; D006261:Headache / Q000188:drug therapy; D006801:Humans; D007022:Hypotension / Q000188:drug therapy; D009325:Nausea / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D011736:Pyridoxine / Q000627:therapeutic use*; D014020:Tissue Extracts / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy
D000970:Antineoplastic Agents; D014020:Tissue Extracts; D011736:Pyridoxine
Trattamento degli effetti tossici collaterali secondari da farmaci antiblastici.